Work

Prognostic value of plasma circulating tumor (ct) DNA KRAS mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.4022

Authors: Julia S. Johansen, Cecile Rose T. Vibat, Saege Hancock, Inna Markovna Chen, Latifa Hassaine, Errin Samuelsz, Eric Andrew Collisson, Benny Vittrup Jensen, Timothy T. Lu, Vlada Melnikova, Mark G. Erlander

Institutions: Herlev Hospital, University of California, San Francisco, Copenhagen University Hospital

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2734898498

Cites:

Cited by: 2

Related to: 10